Fundraising Fox
/People
Sign in

Christopher Gagliardi

Investor

Investor at Sanofi Ventures · Board director at AdvanCell Isotopes

Boston, Massachusetts

Writes $5M – $10M checks · typically $7.5M

Find your path to Christopher

80 people in our graph can introduce you to Christopher.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Gordon McMurray to introduce you to Christopher

You →Gordon · together at Sudo Bio (2023–2026) →Christopher

Ask Jamie Chen to introduce you to Christopher

You →Jamie · 2 people · together at Sudo Bio →Christopher

Ask Sam Okafor to introduce you to Christopher

You →Sam · 4 people · together at NextPoint Therapeutics →Christopher

Sign up to find every way you can get introduced to Christopher

  • Your email: the people you already email who know Christopher
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Christopher
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Christopher Gagliardi is Ph.D.-trained with a consulting background, serves as Board Observer at Lifordi Immunotherapeutics, and is publicly associated with over 40 life sciences and healthcare investments.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Board director at AdvanCell Isotopes

Intro paths

→

In turn, Christopher can intro founders to AdvanCell Isotopes's investors below.

AdvanCell Isotopes's investors · 9

AbingworthLondon · $15M – $30M checks · since 2026Ally Bridge GroupNew York · since 2026Bain Capital Life SciencesBoston · since 2026Catalio Capital Management, LPNew York · since 2026Proto AxiomSydney · since 2026Sanofi VenturesCambridge · $5M checks · since 2026SV Health InvestorsLondon · $1M – $20M checks · since 2026T. Rowe PriceBaltimore · since 2026Tenmilesince 2026

Co-founders at AdvanCell Isotopes

AAAndrew Adamovich
Andrew AdamovichDirector

Experience

  1. SanofiPrincipal, Sanofi Venturescurrent2023 — presentGreater Boston
  2. SanofiDirector of Investments, Sanofi Ventures2017 — 2023Greater Boston
  3. QuantX BiosciencesBoard Membercurrent2025 — presentShanghai, China
  4. Diagonal TherapeuticsBoard Observercurrent2026 — presentBoston, Massachusetts, United States
  5. AdvanCellBoard Membercurrent2024 — presentBrisbane, Queensland, Australia
  6. Atalanta TherapeuticsBoard Observercurrent2024 — presentBoston, Massachusetts, United States
  7. Sudo BiosciencesBoard Membercurrent2023 — presentCarmel, Indiana, United States
  8. Minervax ApSBoard Membercurrent2020 — presentCopenhagen, Capital Region of Denmark, Denmark
  9. Avilar TherapeuticsBoard Observercurrent2023 — presentGreater Boston
  10. NextPoint Therapeutics, Inc.Board Observercurrent2022 — presentGreater Boston
  11. Matchpoint TherapeuticsBoard Observercurrent2022 — presentGreater Boston
  12. i2o TherapeuticsBoard Membercurrent2020 — presentGreater Boston
  13. L.E.K. ConsultingConsultant2015 — 2017Greater Boston
  14. Graz University of TechnologyResearch Assistant/Intern, Department of Inorganic Chemistry2006Graz, Austria
  15. Marine Biological LaboratoryMarine Resources Center2005Woods Hole, Massachusetts

Skills & more

Spectroscopy7Electrochemistry4UV/Vis5Life Sciences5Strategy2Financial Modeling1Asset Life Cycle Management1Pharmaceutical Industry2Biotechnology1Revenue Forecasting

Languages I have a basic knowledge of German

From Christopher's professional profile.

Investments

Sources: SEC Form D filings · curated public sources.

Colleagues at Sanofi Ventures

Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Francesc
Investor at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason
Investor at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures

Network4

Cris De Luca
Partner, Digital at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Jim Trenkle
Investor at Sanofi Ventures
Laia Crespo
Partner at Sanofi Ventures

Investors connected to Christopher in public investor directories — a warm-intro map.

Frequently asked questions

Who is Christopher Gagliardi?
Christopher Gagliardi is Ph.D.-trained with a consulting background, serves as Board Observer at Lifordi Immunotherapeutics, and is publicly associated with over 40 life sciences and healthcare investments.
Where does Christopher Gagliardi work?
Christopher Gagliardi is Investor at Sanofi Ventures and Board director at AdvanCell Isotopes.
What does Christopher Gagliardi invest in?
Christopher Gagliardi invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
What check size does Christopher Gagliardi write?
Christopher Gagliardi typically writes checks of $5M – $10M.
What boards does Christopher Gagliardi sit on?
Christopher Gagliardi holds tracked board seats at AdvanCell Isotopes.
What companies has Christopher Gagliardi invested in?
Investments tracked here include AdvanCell Isotopes, I2 Therapeutics, Lifordi Immunotherapeutics, MinervaX, Quantxbio, Sudo Bio.
Where did Christopher Gagliardi go to school?
Christopher Gagliardi studied at Harvard University (Postdoctoral Research Fellow); The University of North Carolina at Chapel Hill (Doctor of Philosophy (Ph.D.), Inorganic Chemistry); Roger Williams University (Bachelor of Science (B.S.) Chemistry, Bachelor of Science (B.S.) Biology).

Same school

Shared employers

Also worked at Atalanta Therapeutics1

Arno de WildeInvestor at EQT Life Sciences